Tango Therapeutics Inc is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNGX is expected to report earnings to -32 cents per share on August 12
Q2'26
Est.
$-0.32
Q1'26
Missed
by $0.01
Q4'25
Beat
by $0.03
Q3'25
Missed
by $0.07
Q2'25
Est.
$-0.35
The last earnings report on May 13 showed earnings per share of -31 cents, missing the estimate of -31 cents. With 905.21K shares outstanding, the current market capitalization sits at 4.64B.